RNU6-1282P

Across TCGA pan-cancer cohorts, RNU6-1282P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1282P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-1282P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1282P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

LIHC, KIRP, and BLCA are the cancer types where RNU6-1282P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.304	0.704	<.001	81	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
BLCA	OS	Tertile	IV	0.073	0.592	<.001	27	view →
HNSC	DFS	Tertile	All	0.138	0.379	.002	27	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	21	view →
PAAD	OS	Tertile	II,III,IV	0.363	0.570	.039	18	view →
CESC	DFS	Tertile	IV	0.235	0.554	.035	18	view →
THCA	OS	Tertile	All	0.550	0.968	<.001	15	view →
SKCM	DFS	Tertile	III,IV	0.834	0.242	.031	6	view →
LUSC	OS	Tertile	All	0.295	0.411	.040	6	view →
STAD	DFS	Quartile	IV	0.137	0.519	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1282P–LIHC (OS)

Open the LIHC breakdown →